Yes, men can be tested for trichomoniasis, but the testing is less straightforward than for women and depends heavily on which test is used. The most reliable method is a nucleic acid amplification test (NAAT) on a urine sample or urethral swab, which detects the parasite's DNA with roughly 95 to 100 percent sensitivity. Microscopy of urine or urethral discharge is far weaker in men, catching only about 40 to 60 percent of infections. Because up to 70 percent of infected men have no symptoms, testing is often the only way to find the infection and stop it from spreading.
How the parasite behaves in the male body
Trichomonas vaginalis is a single-celled protozoan with four flagella and a pear-shaped body about 10 micrometers long. In women it colonizes the vagina and can cause vaginitis. In men it settles in the urethra, the prostate, and sometimes the epididymis. That anatomical difference is the single biggest reason male testing is harder.
The organism does not need to invade tissue to survive. It attaches to the urethral lining and multiplies in the moist environment. In men, the parasite load tends to be lower than in women, and it clears on its own within weeks to months in a meaningful share of cases. One often-cited figure puts spontaneous clearance at roughly 30 percent of infected men over several months. That lower and sometimes transient burden is exactly what defeats low-sensitivity tests.
A second mechanism matters. T. vaginalis does not trigger the same heavy inflammatory response in the male urethra that it does in the vagina. Many infected men produce few white blood cells in their urine, so a urinalysis may look nearly normal. In plain terms: the bug can be present without leaving the usual footprints that simpler tests look for.
The parasite also forms relationships with other organisms. It can harbor Trichomonas vaginalis virus, and infection is linked to a roughly 1.5- to 2-fold higher risk of acquiring HIV. That association is well established; the precise direction of cause and effect remains an area of active study.
What each test actually detects
Four test classes are available for men, and they differ enormously in sensitivity, cost, and speed. The numbers below come from comparative studies and clinical guidelines, including the CDC's 2021 sexually transmitted infections treatment guidelines.
| Test method | What it detects | Sensitivity in men | Turnaround | Typical cost (US) |
|---|---|---|---|---|
| NAAT (urine or urethral swab) | Parasite DNA | 95–100% | 1–3 days | USD 50–150 |
| Microscopy (wet mount) | Live motile organisms | 40–60% | Minutes | USD 10–30 |
| Culture (urethane broth) | Viable organisms | 70–85% | 3–7 days | USD 30–80 |
| Rapid antigen/point-of-care | Parasite proteins | 60–85% | 15–30 minutes | USD 20–60 |
NAAT is now the recommended first-line test for men per the CDC's 2021 guidance. It amplifies specific DNA sequences, so it works even when only a few organisms are present. Culture is a reasonable fallback in labs without NAAT capacity, but it requires live parasites and a week of incubation. Microscopy is fast and cheap but misses more than half of infections in men, which is why it should never be used to rule out the disease.
One older test, the OSOM Trichomonas Rapid Test, was widely used but is no longer recommended as a standalone method because of variable sensitivity. In plain terms: the cheap, instant tests are convenient but can give false reassurance.
Why so many infections go undetected
Symptom data explains the testing gap. Among infected men, roughly 60 to 70 percent report no symptoms at all. When symptoms do appear, they are mild: a thin urethral discharge, burning with urination, or irritation at the tip of the penis. These overlap with chlamydia and gonorrhea, so a man with urethritis may be treated empirically without ever being tested for trichomoniasis.
When symptoms arise, they usually show up 5 to 28 days after exposure, though many cases never declare themselves. That window is longer and blurrier than for gonorrhea, which often produces discharge within 2 to 5 days. The delayed and quiet course means a man can transmit the parasite for months without knowing he carries it.
Prevalence numbers are uneven. In the general US male population, T. vaginalis prevalence is roughly 1 to 3 percent by NAAT. In men attending sexually transmitted infection clinics, the figure rises to 5 to 15 percent. Among men who have sex with men, prevalence is generally reported as lower than in heterosexual men, though screening studies find meaningful rates in those with other STIs.
Transmission dynamics and reinfection math
The parasite spreads through direct genital-to-genital contact, not through casual touching or shared towels in any meaningful way. Condoms reduce transmission but do not eliminate it, because the parasite can sit on skin the condom does not cover, including the scrotum and perineum.
Reinfection rates are the strongest argument for treating and testing partners. If a man is treated but his partner is not, reinfection rates run around 10 to 30 percent within a few months in published cohorts. Successful treatment with a single 2-gram dose of metronidazole clears roughly 90 to 95 percent of infections. The residual failures are mostly reinfections from untreated partners rather than drug resistance, though nitroimidazole-resistant strains do exist and are rising in some regions.
The math is worth spelling out. If a man's infection clears at 95 percent with treatment and his partner remains infected, his reinfection probability per act of unprotected sex is estimated at 20 to 30 percent. Over multiple exposures, the cumulative risk approaches certainty. That is why the CDC recommends treating all sexual partners and retesting men 3 months after treatment.
When testing misses: false negatives and edge cases
A negative NAAT is not a guarantee. Sensitivity of 95 percent means about 5 in 100 infected men test negative on a single sample. If suspicion is high, repeat testing or a different sample type (urethral swab instead of urine) can close the gap.
Sample collection matters. First-void urine, meaning the first 10 to 20 milliliters of the stream, concentrates organisms from